Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.
about
In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian CancerUpdate on Imaging of Ovarian Cancer25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesTherapy response with diffusion MRI: an updatePhylogenetic quantification of intra-tumour heterogeneitySpatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysisPractical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationWhole body MRI: improved lesion detection and characterization with diffusion weighted techniquesModelling DW-MRI data from primary and metastatic ovarian tumours.Diffusion MRI in early cancer therapeutic response assessment.Intrabiliary RF heat-enhanced local chemotherapy of a cholangiocarcinoma cell line: monitoring with dual-modality imaging--preclinical study.Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.New ways of assessing ovarian cancer response: metabolic imaging and beyondMolecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinomaDiffusion-Weighted Imaging of Small Peritoneal Implants in "Potentially" Early-Stage Ovarian Cancer.Molecular Imaging of Ovarian CancerDiffusion-weighted MRI monitoring of pancreatic cancer response to radiofrequency heat-enhanced intratumor chemotherapy.DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic.Effect of color visualization and display hardware on the visual assessment of pseudocolor medical images.Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts.Functional MR imaging in gynecologic malignancies: current status and future perspectives.A framework for optimization of diffusion-weighted MRI protocols for large field-of-view abdominal-pelvic imaging in multicenter studies.Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model.Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.What's New in Imaging for Gynecologic Cancer?Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study.Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
P2860
Q26742109-1FCFBC30-1DF7-4CBA-8CCE-B27B13FC874AQ26750610-8599B676-4F5C-4FA5-9BF0-A48867CC9857Q26774810-54294A33-BC86-4E35-9BA2-79C80FE58EABQ26851700-226D6840-B7AD-4159-ADEA-1AB1958B4B42Q28537974-41945A09-9A6E-432D-83FF-E1499DD95AA2Q28649475-2DC4427B-5BA3-4894-AB34-98182AC59D5CQ30575110-586D4AF4-81AD-4503-BD2F-52455B8A9DC1Q30662431-0CC084AA-5095-454E-A2C1-69A5F163279EQ30885348-92090A8E-7FB8-4DD6-85F5-B93C0AFBBAD3Q31037179-2F98EA48-FCA6-4D2D-ACBF-A8224032BE24Q34495478-E989F667-1C43-444B-8209-594C00D0C815Q35609995-93F51DCC-DE22-4C1B-B5A2-A440E7D0B9CEQ36286480-EB993839-6393-4122-A48E-CCC40CCD82ABQ36511080-9806DC94-1CAE-48E7-BF60-8AD7B429078CQ36679753-A7D3D7B9-B335-4A6C-898E-067A21666CEDQ37305724-FD763DD0-B34A-4B72-BA1A-9C7086DBA157Q37337120-B5230DC9-1AD9-4278-977F-A099A32268F5Q37368258-E3564EA6-F21D-4F8F-AC25-4DF3201BEDCDQ37490121-6A558C8A-8B60-47A9-8AC1-E47F5F261AF0Q37559012-65417F46-AB0C-4F4C-82BD-63F6B86F20D1Q37654901-505595CD-E0C4-48CB-80C7-EA76C12EB46AQ38811494-DA30DBDA-3D4D-4BDC-971C-7D5E744F74E1Q40128519-C71182EE-C8C7-4113-9E9A-4815C1B5FCE0Q41261406-92DB405E-D123-4D43-A538-CCF4E62C17EBQ41549845-24D1ECBD-E0D3-48D4-AF4A-23FC53C3E667Q41571576-C097CA1C-B8E8-40C7-A011-6E6692D16252Q44770864-55434191-2BC2-40A3-9F5B-046C3CBA9DB7Q50145613-9BB48ADA-718F-4C27-8819-6FBB9A98381AQ50754613-A0C6F821-05DD-47DB-A0D8-77BB46CA1935Q54270019-A5811AC8-975A-4530-B07E-D662B4642321
P2860
Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Advanced ovarian cancer: multi ...... d metastasis-specific effects.
@en
Advanced ovarian cancer: multi ...... d metastasis-specific effects.
@nl
type
label
Advanced ovarian cancer: multi ...... d metastasis-specific effects.
@en
Advanced ovarian cancer: multi ...... d metastasis-specific effects.
@nl
prefLabel
Advanced ovarian cancer: multi ...... d metastasis-specific effects.
@en
Advanced ovarian cancer: multi ...... d metastasis-specific effects.
@nl
P2093
P50
P356
P1433
P1476
Advanced ovarian cancer: multi ...... d metastasis-specific effects.
@en
P2093
Andrew B Gill
Charlotte Hodgkin
David J Lomas
Helena M Earl
Ilse Joubert
John R Griffiths
Mary A McLean
Masako Y Kataoka
Mercedes Jimenez-Linan
P304
P356
10.1148/RADIOL.11110175
P407
P577
2012-02-13T00:00:00Z